The main findings of the study were as follows: MALAT1 promotes oncogenesis and enhances KRAS/mitogen-activated protein kinase (MAPK) signalling pathway activation in pancreatic cancer at least in part through a direct interaction with miR-217. This evidence concerns the gene KRAS and pancreatic neoplasm.